Additionally, while previous histological studies failed to establish a clear correlation between the level of PSMA expression and tumour grade across samples from different patients [3,4,5], to our knowledge this study is the first to assess the intra-patient correlation between levels of PSMA expression and levels of metabolic activity within the tumour lesion in recurrent GBM patients. This evidence concerns the gene FOLH1 and neoplasm.